NEW YORK (GenomeWeb News) — Bio-Rad Laboratories will pay Ciphergen $2 million once the US Patent and Trademark Office re-issues a SELDI mass-spectrometry-related patent, Ciphergen said yesterday.
Ciphergen said the USPTO has given it a notice of intent to issue a Re-examination Certificate for the patent, entitled “Method and apparatus for desorption and ionization of analytes” and assigned to the Baylor College of Medicine.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.